Literature DB >> 557991

Quantitative studies on lysolecithin-mediated hemolysis. Use of ether-deoxy lysolecithin analogs with varying aliphatic chain-lengths.

H U Weltzien, B Arnold, R Reuther.   

Abstract

The process of lysolecithin-mediated hemolysis has been investigated by use of various ether-deoxy lysolecithin analogs (1-alkyl-propanediol-3-phosphorylcholine) with alkyl residues of 10-22 carbon atoms. Hemolytic activities were defined either as molar amounts to be added for 50% lysis (L50) or as cell-bound amounts at 50% lysis (A50). It was found, that in contrast to L50, A50 values are independent of experimental conditions. Moreover, L50 values primarily reflect the binding affinities, while A50 values give more accurate information on the actual membrane-disturbing potential. The strongest hemolytic C16-lysolecithin analog required 2 - 10(7) or 5 - 10(7) molecules bound per cell for 50% lysis at 0 or 37degrees C, respectively, corresponding to about 10 or 25% of the total membrane phospholipids. Evidence is presented, indicating that (a) lysophosphatides bind to cells below their critical micelle concentration, (b) micelles themselves are not generally necessary for cell lysis. Red cells of different species (man and cattle) as well as at varying temperatures exhibit significantly different sensitivities in terms of L50 and A50 values. These differences, however, depend on the degree of hydrophobicity of the lysolecithins and disappear in the case of lysolipids having C10 or C12 aliphatic residues. The data are in agreement with our hypothesis that cellular sensitivity to lysolecithin lysis may be determined by the degree of segregation of lysolecithin-rich areas within the membrane lipid phase.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557991     DOI: 10.1016/0005-2736(77)90334-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Further evidence for closed, nonspherical aggregates in the cubic I(1) phase of lysolecithin and water.

Authors:  G Lindblom; L B Johansson; G Wikander; P O Eriksson; G Arvidson
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

2.  Solubilization of human red cell membranes by lysolecithins of various chain lengths.

Authors:  E Condrea
Journal:  Experientia       Date:  1980-05-15

3.  The effect of lysophosphatidylcholine on coronary and renal circulation in the rabbit.

Authors:  A Wolf; T Saito; R Dudek; R J Bing
Journal:  Lipids       Date:  1991-03       Impact factor: 1.880

4.  Influence of enzymatic phospholipid cleavage on the permeability of the erythrocyte membrane: III. Discrimination between the causal role of split products and of lecithin removal.

Authors:  B Deuticke; M Grunze; B Forst; P Luetkemeier
Journal:  J Membr Biol       Date:  1981-03-15       Impact factor: 1.843

5.  Lysophosphatidylcholine exhibits selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages.

Authors:  Cheon Ho Park; Mee Ree Kim; Jong-Min Han; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2009-02-28       Impact factor: 1.880

6.  Novel technique for generating macrophage foam cells for in vitro reverse cholesterol transport studies.

Authors:  Bhaswati Sengupta; Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy
Journal:  J Lipid Res       Date:  2013-10-09       Impact factor: 5.922

7.  Schistosomula of Schistosoma mansoni use lysophosphatidylcholine to lyse adherent human red blood cells and immobilize red cell membrane components.

Authors:  D E Golan; C S Brown; C M Cianci; S T Furlong; J P Caulfield
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

8.  A metabolically-stabilized phosphonate analog of lysophosphatidic acid attenuates collagen-induced arthritis.

Authors:  Ioanna Nikitopoulou; Eleanna Kaffe; Ioanna Sevastou; Ivi Sirioti; Martina Samiotaki; Damian Madan; Glenn D Prestwich; Vassilis Aidinis
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.